Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2001 to 2050 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLY (ADP-RIBOSE) GLYCOHYDROLASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0320499\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230744143\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2002\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.029603\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.128294\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230743449\vspace{3pt}}&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2003\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0937028\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.406091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230743356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TXNDC10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTO1 PROTEIN HOMOLOG (CGI-02). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.297474\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.2892\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230743096\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S20. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.834926\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.6186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230731775\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS20\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 1 (EC 2.1.1.43) (HISTONE H3-K9 METHYLTRANSFERASE 1) (H3-K9-HMTASE 1) (SUPPRESSOR OF VARIEGATION 3-9 HOMOLOG 1) (SU(VAR)3-9 HOMOLOG 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.027437\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118935\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230689032\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SUV39H1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 2 SUBUNIT 1 (EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA SUBUNIT) (EIF-2-ALPHA) (EIF- 2ALPHA) (EIF-2A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.761536\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.30114\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230688792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF2S1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 2 (EC 2.1.1.43) (HISTONE H3-K9 METHYLTRANSFERASE 2) (H3-K9-HMTASE 2) (SUPPRESSOR OF VARIEGATION 3-9 HOMOLOG 2) (SU(VAR)3-9 HOMOLOG 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0323264\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.14013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230688646\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SUV39H2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOSIDE DIPHOSPHATE KINASE B (EC 2.7.4.6) (NDK B) (NDP KINASE B) (NM23-H2) (C-MYC PURINE-BINDING TRANSCRIPTION FACTOR PUF). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.533964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.31472\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230681897\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOSIDE DIPHOSPHATE KINASE A (EC 2.7.4.6) (NDK A) (NDP KINASE A) (TUMOR METASTATIC PROCESS-ASSOCIATED PROTEIN) (METASTASIS INHIBITION FACTOR NM23) (NM23-H1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.494361\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.14316\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230669199\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NME2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE NUCLEOSIDE DIPHOSPHATE KINASE (EC 2.7.4.6) (NDK) (NDP KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.480816\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.08449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230663616\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NME2P1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2012\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S2 (S4) (LLREP3 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.469\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.36963\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230625641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN ARGININE N-METHYLTRANSFERASE 3 (EC 2.1.1.-) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0198445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0860464\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230625569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRMT3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2014\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L23 (L17). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.64348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.79016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230624767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRCA2 AND CDKN1A-INTERACTING PROTEIN ISOFORM BCCIPALPHA; BRCA2 AND CDKN1A-INTERACTING PROTEIN; CDK INHIBITOR P21 BINDING PROTEIN; BCCIPALPHA; BCCIPBETA; TOK-1ALPHA; TOK-1BETA. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0167203\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0725001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230624509\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BCCIP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2016\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE EUKARYOTIC TRANSLATION INITIATION FACTOR 1A (EIF-1A) (EIF- 4C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.27676\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.53686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230592791\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2017\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SUCCINATE DEHYDROGENASE [UBIQUINONE] IRON-SULFUR PROTEIN, MITOCHONDRIAL PRECURSOR (EC 1.3.5.1) (IP) (IRON-SULFUR SUBUNIT OF COMPLEX II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.311095\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.34923\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230572252\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SDHB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2018\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S16. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.590899\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2.56327\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.230525462\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS16\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"60S RIBOSOMAL PROTEIN L13, MITOCHONDRIAL (L13MT). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MRPL13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2020\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L13A (23 KDA HIGHLY BASIC PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.587935\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.55045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230522065\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL13A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2021\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"LON PROTEASE HOMOLOG, MITOCHONDRIAL PRECURSOR (EC 3.4.21.-) (LON PROTEASE-LIKE PROTEIN) (LONP) (LONHS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0840355\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.364571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230505169\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2022\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.123498\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.535804\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C11orf79\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2023\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MAGUK P55 SUBFAMILY MEMBER 3 (MPP3 PROTEIN) (DISCS, LARGE HOMOLOG 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.112993\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.490447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230387789\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSKETOLASE (EC 2.2.1.1) (TK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.150764\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.654499\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230350237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TKT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PYRUVATE DEHYDROGENASE E1 COMPONENT ALPHA SUBUNIT, SOMATIC FORM, MITOCHONDRIAL PRECURSOR (EC 1.2.4.1) (PDHE1-A TYPE I). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.38076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.65321\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230315568\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDHA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2026\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0327033\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.142004\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230298442\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C3orf23\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2027\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0370628\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.160934\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230298135\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIN3B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2028\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DENSITY-REGULATED PROTEIN (DRP) (DRP1 PROTEIN) (SMOOTH MUSCLE CELL ASSOCIATED PROTEIN-3) (SMAP-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.469395\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.03821\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230297663\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DENR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRANSCRIPTIONAL CO-REPRESSOR SIN3A; TRANSCRIPTIONAL REGULATOR, SIN3A (YEAST). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0283438\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.123075\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230296973\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIN3A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PYRUVATE DEHYDROGENASE E1 COMPONENT ALPHA SUBUNIT, TESTIS-SPECIFIC FORM, MITOCHONDRIAL PRECURSOR (EC 1.2.4.1) (PDHE1-A TYPE II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.353795\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.53626\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230296304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDHA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN TRANSPORT PROTEIN SEC61 GAMMA SUBUNIT. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.114962\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.499271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230259719\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC61G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.116403\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.505621\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23021789\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRNA PSEUDOURIDINE SYNTHASE A (EC 4.2.1.70) (PSEUDOURIDYLATE SYNTHASE I) (PSEUDOURIDINE SYNTHASE I) (URACIL HYDROLYASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.474475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.06115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230199161\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PUS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2034\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.473995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.05907\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230198585\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PUS3\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2035\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0841705\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.365653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230192286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DARS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.08774\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.7257\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230175424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CASEIN KINASE I ALPHA S-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0896146\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.389336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23017291\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSNK1A1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CASEIN KINASE I, ALPHA ISOFORM (EC 2.7.1.-) (CKI-ALPHA) (CK1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0909346\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.395071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230172804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSNK1A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HUNTINGTIN INTERACTING PROTEIN 1 RELATED (HIP1-RELATED) (HIP 12). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.127824\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.555396\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230149299\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HIP1R\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"40S RIBOSOMAL PROTEIN S4, X ISOFORM (SINGLE COPY ABUNDANT MRNA PROTEIN) (SCR10). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.707942\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.07604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230147202\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"40S RIBOSOMAL PROTEIN S4, Y ISOFORM 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.667613\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.90083\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23014551\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS4Y2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GOODPASTURE ANTIGEN-BINDING PROTEIN (EC 2.7.1.37) (GPBP) (COLLAGEN TYPE IV ALPHA 3 BINDING PROTEIN) (STAR-RELATED LIPID TRANSFER PROTEIN 11) (STARD11) (START DOMAIN-CONTAINING PROTEIN 11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0646597\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.280961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230137635\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COL4A3BP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HUNTINGTIN INTERACTING PROTEIN 1 (HIP-I). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.104281\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.453153\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230123159\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HIP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE II 14.5 KDA POLYPEPTIDE (EC 2.7.7.6) (RPB9) (RPB14.5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.110371\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.479632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230116006\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR2I\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U6 SNRNA-ASSOCIATED SM-LIKE PROTEIN LSM4 (GLYCINE-RICH PROTEIN) (GRP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.308754\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.34189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230088904\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LSM4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE I 40 KDA POLYPEPTIDE (EC 2.7.7.6) (RPA40) (RPA39). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.55851\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.77601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230004088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR1C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INORGANIC PYROPHOSPHATASE 2 ISOFORM 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.123888\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.538763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229948976\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AH RECEPTOR-INTERACTING PROTEIN (AIP) (IMMUNOPHILIN HOMOLOG ARA9) (HBV-X ASSOCIATED PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.052087\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.226516\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229948436\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AIP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INORGANIC PYROPHOSPHATASE (EC 3.6.1.1) (PYROPHOSPHATE PHOSPHO- HYDROLASE) (PPASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.128098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.557073\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229948319\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARYL-HYDROCARBON INTERACTING PROTEIN-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0410498\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.178518\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22994768\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AIPL1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/